Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gloria Lee, MD
HUYABIO International, LLC.
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Akita, Japan
- Facility name not stated
Bunkyōku, Japan
- Facility name not stated
Chūōku, Japan
- Facility name not stated
Fukuoka, Japan
- Facility name not stated
Isehara, Japan
- Facility name not stated
Kagoshima, Japan
- Facility name not stated
Kobe, Japan
- Facility name not stated
Kumamoto, Japan
- Facility name not stated
Kyoto, Japan
- Facility name not stated
Kōtoku, Japan
- Facility name not stated
Maebashi, Japan
- Facility name not stated
Nagoya, Japan
- Facility name not stated
Okayama, Japan
- Facility name not stated
Sapporo, Japan
- Facility name not stated
Sayama, Japan
- Facility name not stated
Suita, Japan
- Facility name not stated
Yamagata, Japan
- Facility name not stated
Ōmura, Japan
- Facility name not stated
Busan, South Korea
- Facility name not stated
Goyang-si, South Korea
- Facility name not stated
Incheon, South Korea
- Facility name not stated
Seongnam-si, South Korea
- Facility name not stated
Seoul, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2016
- Primary completion
- 17 Feb 2022
- Completion
- 17 Feb 2022
- Last update posted
- 19 Sept 2024
- Registered enrollment
- 55
- Registry id
- NCT02953652
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.